Future directions should focus on refining nanotechnology applications to tailor antioxidant interventions based on individual tumour profiles, genetic markers, and the tumour microenvironment

Home Medical news & Guidelines Anesthesiology Cardiology and CTVS Critical Care Dentistry Dermatology Diabetes and Endocrinology ENT Gastroenterology Medicine Nephrology Neurology Obstretics-Gynaecology Oncology Ophthalmology Orthopaedics Pediatrics-Neonatology Psychiatry Pulmonology Radiology Surgery Urology Laboratory Medicine Diet Nursing Paramedical Physiotherapy Health news Fact Check Bone Health Fact Check Brain Health Fact Check Cancer Related Fact Check Child Care Fact Check Dental and oral health fact check Diabetes and metabolic health fact check Diet and Nutrition Fact Check Eye and ENT Care Fact Check Fitness fact check Gut health fact check Heart health fact check Kidney health fact check Medical education fact check Men's health fact check Respiratory fact check Skin and hair care fact check Vaccine and Immunization fact check Women's health fact check AYUSH State News Andaman and Nicobar Islands Andhra Pradesh Arunachal Pradesh Assam Bihar Chandigarh Chattisgarh Dadra and Nagar Haveli Daman and Diu Delhi Goa Gujarat Haryana Himachal Pradesh Jammu & Kashmir Jharkhand Karnataka Kerala Ladakh Lakshadweep Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Puducherry Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttrakhand West Bengal Medical Education Industry GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA Denmark: Researchers have found in a new randomized HISTORI trial that schizophrenia patients on antipsychotics experienced greater weight loss and HbA1c reduction with 1 mg semaglutide compared to placebo

Safety and Side Effects Common Side Effects Injection site discomfort Nausea Mild allergic reactions Serious Risks Severe allergic reactions (rare) Improper use complications Medical supervision is essential during treatment
The rise in cAMP leads, in turn, to activation of protein kinase A (PKA) and enhanced signalling via exchange proteins directly activated by cAMP (EPACs), in particular EPAC2
3.4 MAPKAPK2 kinase activity is required for its cytoprotective effects under oxidative stress To determine whether the antioxidant and cytoprotective effects observed above are dependent on MAPKAPK2 enzymatic activity rather than protein abundance alone, giving that MAPKAPK2 is a serine/threonine kinase, changes in its expression alone may not necessarily reflect functional activation
This study underscores the vulnerability of CPT I, CPT II, and carnitine homeostasis to oxidative stress in a widely used in vitro model of ischemia and reperfusion [54]